Literature DB >> 19304393

Two novel SCN9A mutations causing insensitivity to pain.

K B Nilsen1, A K Nicholas, C G Woods, S I Mellgren, M Nebuchennykh, J Aasly.   

Abstract

The sensation of pain is important and there may be serious consequences if it is missing. Recently, the genetic basis for a channelopathy characterised by a congenital inability to experience pain has been described and channelopathy-associated insensitivity to pain has been proposed as a suitable name for this condition. Different mutations in the SCN9A gene causing loss of function of the voltage-gated sodium channel Nav1.7 have been reported in patients with this rare disease. Here we describe a woman with insensitivity to pain with two novel mutations in the SCN9A gene, coding for the Nav1.7 channel. We also discuss the finding of anosmia which apparently is a common feature in these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304393     DOI: 10.1016/j.pain.2009.02.016

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  43 in total

1.  A nonsense mutation in the SCN9A gene in congenital insensitivity to pain.

Authors:  Mazen Kurban; Muhammad Wajid; Yutaka Shimomura; Angela M Christiano
Journal:  Dermatology       Date:  2010-07-13       Impact factor: 5.366

Review 2.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 3.  The physiological function of different voltage-gated sodium channels in pain.

Authors:  George Goodwin; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2021-03-29       Impact factor: 34.870

Review 4.  Genetic variability of pain perception and treatment--clinical pharmacological implications.

Authors:  Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2011-02-23       Impact factor: 2.953

5.  Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability.

Authors:  Jianying Huang; Carlos G Vanoye; Alison Cutts; Y Paul Goldberg; Sulayman D Dib-Hajj; Charles J Cohen; Stephen G Waxman; Alfred L George
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

Review 6.  Anosmia-A Clinical Review.

Authors:  Sanne Boesveldt; Elbrich M Postma; Duncan Boak; Antje Welge-Luessen; Veronika Schöpf; Joel D Mainland; Jeffrey Martens; John Ngai; Valerie B Duffy
Journal:  Chem Senses       Date:  2017-09-01       Impact factor: 3.160

7.  Impact of the NaV1.8 variant, A1073V, on post-sigmoidectomy pain and electrophysiological function in rat sympathetic neurons.

Authors:  Matthew D Coates; Joyce S Kim; Nurgul Carkaci-Salli; Kent E Vrana; Walter A Koltun; Henry L Puhl; Sanjib D Adhikary; Piotr K Janicki; Victor Ruiz-Velasco
Journal:  J Neurophysiol       Date:  2019-10-23       Impact factor: 2.714

Review 8.  The Na(V)1.7 sodium channel: from molecule to man.

Authors:  Sulayman D Dib-Hajj; Yang Yang; Joel A Black; Stephen G Waxman
Journal:  Nat Rev Neurosci       Date:  2012-12-12       Impact factor: 34.870

9.  Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations.

Authors:  James J Cox; Jony Sheynin; Zamir Shorer; Frank Reimann; Adeline K Nicholas; Lorena Zubovic; Marco Baralle; Elizabeth Wraige; Esther Manor; Jacov Levy; C Geoffery Woods; Ruti Parvari
Journal:  Hum Mutat       Date:  2010-09       Impact factor: 4.878

Review 10.  New and developing drugs for the treatment of neuropathic pain in diabetes.

Authors:  Roy Freeman
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.